| | |  | | | | Record from Web of Science® | | | | | | |
| Therapy-related myeloid leukemia |
|
|
| Author(s): Thirman MJ, Larson RA |
| Source: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA Volume: 10 Issue: 2 Pages: 293-& Published: APR 1996 |
| Times Cited: 96 References: 140 |
| Abstract: One of the most serious possible consequences of cancer therapy is the development of a second cancer, especially leukemia. Several distinct subsets of therapy-related leukemia can be distinguished currently. These include classic therapy-related myeloid leukemia, leukemia that follows treatment with agents that inhibit topoisomerase II, acute lymphoblastic leukemia, and leukemias with 21q22 rearrangements or inv(16) or t(15;17). These types of leukemia are discussed in detail in this article. |
| Document Type: Review |
| Language: English |
Addresses:
1. UNIV CHICAGO, PRITZKER SCH MED, HEMATOL ONCOL SECT, CHICAGO, IL 60637 USA
2. UNIV CHICAGO, CANC RES CTR, CHICAGO, IL 60637 USA |
| Publisher: W B SAUNDERS CO, INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 |
| Subject Category: Oncology; Hematology |
| IDS Number: UC649 |
| ISSN: 0889-8588 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |